NOVEMBER 2022LIFE SCIENCES REVIEW4CONTENTSLAST WORD30Accelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsHua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab08Optimizing Alkermes' R&D Model for SuccessCraig Hopkinson,M.D., CMO and Executive Vice President, Research and Development, AlkermesIN MY OPINIONCOVER STORY12GYN PATH Services, Inc. CLINICAL LABORATORY DEDICATED TO WOMEN'S HEALTHCARE ANITA K. MILES, EXECUTIVE DIRECTOR
< Page 3 | Page 5 >